Related Experiment Video

Updated: Dec 6, 2025

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

3.3K

The role of Aurora-A in human cancers and future therapeutics

Xinrong Lin1, Xiaosong Xiang2, Liping Hao1

  • 1Department of Medical Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University Nanjing, China.

American Journal of Cancer Research
|October 12, 2020
PubMed

Insights

Aurora-A, a key mitotic kinase and oncogene, drives tumor growth, invasion, and metastasis. Inhibiting Aurora-A shows promise in cancer therapy, with clinical trials ongoing.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Aurora-A is a serine/threonine-protein kinase crucial for cell division.
  • In normal cells, it regulates centrosome function and spindle assembly.
  • Abnormal Aurora-A expression is linked to tumorigenesis.

Purpose of the Study:

  • To elucidate the multifaceted roles of Aurora-A in cancer.
  • To explore its non-mitotic functions in tumor progression.
  • To review its involvement in therapeutic resistance and immunotherapy.

Main Methods:

  • Literature review of Aurora-A's function in normal and tumor cells.
  • Analysis of Aurora-A's interactions with mitotic and non-mitotic substrates.
  • Examination of Aurora-A's role in chemoresistance, radiotherapy, and immunotherapy.

Main Results:

  • Aurora-A overexpression promotes cell proliferation, invasion, and metastasis.
  • It regulates key mitotic substrates (PP1, PLK1, TPX2, LAST2).
  • Aurora-A contributes to therapeutic resistance and impacts tumor immunity.

Conclusions:

  • Aurora-A is a significant oncogene with critical roles in tumor progression.
  • Targeting Aurora-A presents a promising therapeutic strategy for cancer treatment.
  • Ongoing clinical trials are evaluating Aurora-A inhibitors for clinical application.
Keywords:
Aurora-Acancerclinical

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.6K